Find your next paid study

UNC Lineberger Comprehensive Cancer CenterNCT06896162

Actual pay is set by the research site.

Phase 1

A Phase Ib/II, Open-label, Multi-centre, Platform Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Multiple Anti-Cancer Agents in Metastatic Prostate Cancer

The purpose of the study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of multiple anti-cancer age…

Metastatic Prostate Cancer

~$150 – $4,500

Actual pay is set by the research site.

AstraZenecaNCT07590934

Blood Loss, SurgicalPostoperative Hemorrhage

Feasibility Evaluation of a Strap-Based Wearable Optical Device (Hemorai Vysio) for Monitoring Hemodynamic Trends and Early Indicators of Blood Loss in Perioperative and Postoperative Patients

The goal of this clinical trial is to learn whether the Hemorai Vysio wearable device can be used safely and feasibly to track relative changes over time in ti…

Lymphomatoid PapulosisMycosis Fungoides

~$10 – $1,050

Actual pay is set by the research site.

Hemorai IncNCT07826637

Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis

To follow up with all our participants with juvenile-onset mycosis fungoides, check on their status, and ask them or their parents about long term outcomes ass…

M.D. Anderson Cancer CenterNCT06207812

Actual pay is set by the research site.

Phase 4

Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)

The primary objective of this study is to examine whether exercise training alone, liraglutide treatment alone or exercise training plus liraglutide treatment …

Type2 Diabetes

University of VirginiaNCT03883412

~$25 – $1,000

Actual pay is set by the research site.

Phase 3

Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, …

Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more

SWOG Cancer Research NetworkNCT07383441

~$50 – $2,250

Actual pay is set by the research site.

Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning

This study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiat…

Malignant Solid NeoplasmHematopoietic and Lymphatic System Neoplasm

Actual pay is set by the research site.

Mayo ClinicNCT06200116

Clinical and Electrographic Changes in RNS System Patients With Acupuncture Treatment

The purpose of this study is to determine effects of Acupuncture on a Patient's mood and cognition,evaluate changes in clinically-reported seizure frequency an…

Epilepsy

The University of Texas Health Science Center, HoustonNCT04677751

Actual pay is set by the research site.

A Pilot Investigation of Pain Reprocessing Therapy for Functional Dyspepsia

The purpose of this research is to test whether pain processing therapy, a novel psychological intervention that emphasizes exposure-based techniques, can redu…

Functional Dyspepsia

Advanced Unresectable Hepatocellular Carcinoma

Actual pay is set by the research site.

Mayo ClinicNCT07838324

Phase 2

A Phase 2a, Multicenter, Randomized, Open-Label Study to Assess the Efficacy, Safety, and Tolerability of RBS2418 in Combination With Tremelimumab Plus Durvalumab for Participants With Advanced Unresectable Hepatocellular Carcinoma

RBS2418 is a targeted immune modulator that inhibits ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). It is designed to promote anti-tumor immunity …

Riboscience, LLC.NCT07175441

~$75 – $2,800

Actual pay is set by the research site.

Phase 3

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure (AMAZE 3)

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated wi…

ObesityOverweightObstructive Sleep Apnoea

Novo Nordisk A/SNCT07571005

~$50 – $2,250

Actual pay is set by the research site.

Abdominal Pain (AP)Disorders of Gut-brain Interaction

Transauricular Neurostimulation for Irritable Bowel Syndrome

This single-site, open-label pilot study will evaluate transcutaneous auricular neurostimulation using the Sparrow Link device as a treatment for adolescents a…